1-12 of 12
Rosanna Mirabelli
Close
Sort by
Journal Articles

Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis

Clinical Trials & Observations
Stefano Molica, Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Neil E. Kay, Tait D. Shanafelt
Journal: Blood
Blood (2018) 131 (3): 365–368.
https://doi.org/10.1182/blood-2017-09-806034
Published: 2018
Includes: Supplemental data
Journal Articles

A Simple Score, Based on Geriatric Assessment, Predicts Survival in Elderly Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Stefano Molica, MD, Diana Giannarelli, PhD, Luciano Levato, MD, Rosanna Mirabelli, MD, Domenico Levato, MD, Mirella Lentini, PhD, Eugenio Piro, MD, Daniela Zappalà, PhD
Journal: Blood
Blood (2016) 128 (22): 2036.
https://doi.org/10.1182/blood.V128.22.2036.2036
Published: 2016
Journal Articles

Is the International Prognostic INDEX for CLL (CLL-IPI) Useful to Predict Time to First Treatment of Patients with EARLY Disease? Results of a Prospective Multicenter Analysis

Stefano Molica, MD, Diana Giannarelli, MD, Luciano Levato, MD, Rosanna Mirabelli, MD, Massimo Gentile, MD, Fortunato Morabito, MD
Journal: Blood
Blood (2015) 126 (23): 498.
https://doi.org/10.1182/blood.V126.23.498.498
Published: 2015
Journal Articles

VITAMIN D Insufficiency Affects Time to FIRST TREATMENT (TFT) In EARLY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Stefano Molica, MD, Giovanna Digiesi, MD, Anna Antenucci, MD, Luciano Levato, Rosanna Mirabelli, MD, Massimo Gentile, MD, Diana Giannarelli, MD, Isabella Sperduti, PhD, Fortunato Morabito, MD, Laura Conte, MD
Journal: Blood
Blood (2011) 118 (21): 4601.
https://doi.org/10.1182/blood.V118.21.4601.4601
Published: 2011
Journal Articles

Efficacy and Safety of a First Line Combined Therapeutic Approach for Young CLL Patients with Advanced or Progressive Disease Stratified According to the Biologic Features: First Analysis of the GIMEMA Multicenter Study LLC0405

Francesca Romana Mauro, MD, Stefano Molica, MD, Agostino Cortelezzi, MD, Alfonso Piciocchi, BS, Luca Laurenti, MD, Maura Brugiatelli, MD, Rita Rizzi, MD, Rosanna Mirabelli, MD, Francesco Zaia, MD, Fabio Stagno, MD, Stefania Ciolli, MD, Francesco Forconi, MD, Vincenzo Callea, MD, Francesco Angrilli, MD, Musolino Caterina, MD, Francesco Buccisano, MD, Massimo Massaia, MD, Giovanni Del Poeta, MD, Simona Santangelo, PhD, Marilisa Marinelli, PhD, Mauro Nanni, PhD, Maria Stefania De Propriis, PhD, Ilaria Del Giudice, MD, Marco Vignetti, MD, Fortunato Morabito, MD, Giuseppe Torelli, MD, Sergio Storti, MD, Alessandro Levis, MD, A. M. Michele Carella, MD, Francesco Di Raimondo, MD, Giuseppe Leone, MD, Francesco Lauria, MD, Giorgina Specchia, MD, Antonio Cuneo, Giovanna Meloni, MD, Anna Guarini, PhD, Robin Foá, MD
Journal: Blood
Blood (2010) 116 (21): 2471.
https://doi.org/10.1182/blood.V116.21.2471.2471
Published: 2010
Journal Articles

Serum CD26 (Dipeptidyl Peptidase IV, DPP IV) compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Stefano Molica, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Rosanna Mirabelli, MD, Giovanna Digiesi, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Fortunato Morabito, Manlio Ferrarini, MD
Journal: Blood
Blood (2008) 112 (11): 4187.
https://doi.org/10.1182/blood.V112.11.4187.4187
Published: 2008
Journal Articles

Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Stefano Molica, MD, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Giovanna Digiesi, MD, Rosanna Mirabelli, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Manlio Ferrarini, MD
Journal: Blood
Blood (2008) 112 (11): 4158.
https://doi.org/10.1182/blood.V112.11.4158.4158
Published: 2008
Journal Articles

Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Stefano Molica, MD, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Giovanna Digiesi, MD, Rosanna Mirabelli, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Manlio Ferrarini, MD
Journal: Blood
Blood (2007) 110 (11): 3093.
https://doi.org/10.1182/blood.V110.11.3093.3093
Published: 2007
Journal Articles

Serum Adiponectin Compared with ZAP-70, CD38 and Immunoglobulin Heavy-Chain Mutation Status as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Stefano Molica, MD, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Giovanna Digiesi, MD, Rosanna Mirabelli, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Manlio Ferrarini, MD
Journal: Blood
Blood (2006) 108 (11): 2786.
https://doi.org/10.1182/blood.V108.11.2786.2786
Published: 2006
Journal Articles

Intense Reversal of Bone Marrow Angiogenesis after Consolidation Therapy with Alemtuzumab in Advanced Chronic Lymphocytic Leukemia.

Stefano Molica, MD, Marco Montillo, MD, Domenico Ribatti, MD, Rosanna Mirabelli, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Silvio Veronese, MD, Angelo Vacca, MD, Enrica Morra, MD
Journal: Blood
Blood (2006) 108 (11): 4985.
https://doi.org/10.1182/blood.V108.11.4985.4985
Published: 2006
Journal Articles

Characteristics and Outcome of B-Cell Chronic Lymphocytic Leukemia in HCV-Positive Patients.

Stefano Molica, MD, Rosanna Mirabelli, MD, Demetrio Misuraca, MD, Caterina Battaglia, MD
Journal: Blood
Blood (2005) 106 (11): 4986.
https://doi.org/10.1182/blood.V106.11.4986.4986
Published: 2005
Journal Articles

Serum Insulinlike Growth Factor Is Not Elevated in Patients with Early B-Cell Chronic Lymphocytic Leukemia but Is Still a Prognostic Factor for Disease-Progression.

Stefano Molica, MD, Gaetano Vitelli, MD, Rosanna Mirabelli, MD, Giovanna Digiesu, MD, Diana Giannarelli, MD, Antonella Iorfida, PhD
Journal: Blood
Blood (2004) 104 (11): 4786.
https://doi.org/10.1182/blood.V104.11.4786.4786
Published: 2004